Arginine: Too much of a good thing may be bad!

Critical Care Medicine

Volumn 34, Issue 11, 2006, Pages 2844-2847

  Marik, Paul E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Arginine; Enteral nutrition; Immunonutrition; Nitric oxide; Sepsis

Indexed keywords

ANTIOXIDANT; ARGININE; GLUTAMINE; GROWTH HORMONE; HYDROXYPROLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OMEGA 3 FATTY ACID; PROLACTIN; SOMATOMEDIN;

AMINO ACID ANALYSIS; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL ACTIVITY; BLOOD FLOW; CATABOLISM; CLINICAL TRIAL; CRITICAL ILLNESS; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; EDITORIAL; ENTERIC FEEDING; HORMONAL REGULATION; HUMAN; IMMUNOMODULATION; INFECTIOUS COMPLICATION; INFLAMMATION; INTENSIVE CARE; LENGTH OF STAY; LYMPHOCYTE FUNCTION; MORTALITY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; SEPSIS; TISSUE INJURY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UREA CYCLE;

ANIMALS; ARGININE; DOGS; ENTERAL NUTRITION; HUMANS; IMMUNOLOGIC FACTORS; NITRIC OXIDE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; SHOCK, SEPTIC;

EID: 33750276614     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000242922.42660.91     Document Type: Editorial

References (56)

1. Zaloga GP, Siddiqui R, Terry C, et al: Arginine: Mediator or modulator of sepsis? Nutr Clin Pract 2004; 19:201-215
2. Beale RJ, Bryg DJ, Bihari DJ: Immunonutrition in the critically ill: A systematic review of clinical outcome. Crit Care Med 1999; 27:2799-2805
3. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953
4. Zaloga GP: Immune-enhancing enteral diets: Where's the beef? Crit Care Med 1998; 26:1143-1146
5. Bruins MJ, Soeters PB, Lamers WH, et al: L-arginine supplementation in hyperdynamic endotoxemic pigs: Effect on nitric oxide synthesis by the different organs. Crit Care Med 2002; 30:508-517
6. Bune AJ, Shergill JK, Cammack R, et al: L-arginine depletion by arginase reduces nitric oxide production in endotoxic shock: An electron paramagnetic resonance study. FEBS Letters 1995; 366:127-130
7. Gomez-Jimenez J, Salgado A, Mourelle M, et al: L-arginine nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
8. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012
9. Heyland DK: Immunonutrition in the critically ill: Putting the cart before the horse? Nutr Clin Pract 2002; 17:267-272
10. Suchner U, Heyland DK, Peter K: Immunemodulatory actions of arginine in the critically ill. Br J Nutr 2002; 87(Suppl 1):S121-S132
11. Marik PE: The cardiovascular dysfunction of sepsis: A NO• and L-arginine deficient state? Crit Care Med 2003; 31:971-973
12. Ochoa JB, Strange J, Kearney P, et al: Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN 2001; 25:23-29
13. Rodriguez PC, Zea AH, Culotta KS, et al: Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 2002;277:21123-21129
14. Taheri F, Ochoa JB, Faghiri Z, et al: L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res 2001; 7:958s-965s
15. Peng HB, Spiecker M, Liao JK: Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998; 161:1970-1976
16. Spiecker M, Darius H, Kaboth K, et al: Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 1998; 63:732-739
17. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997; 272:30969-30974
18. Fowler AA III, Fisher BJ, Sweeney LB, et al: Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: Effects on endothelial function. Biochem Cell Biol 1999; 77:201-208
19. Walley KR, McDonald TE, Higashimoto Y, et al: Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 1999; 160:698-704
20. Meldrum DR, McIntyre RC, Sheridan BC, et al: L-arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 1997; 43:888-893
21. Laroux FS, Lefer DJ, Kawachi S, et al: Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal 2000; 2:391-396
22. Sundrani R, Easington CR, Mattoo A, et al: Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Crit Care Med 2000; 28:2898-2903
23. Gerlach M, Keh D, Bezold G, et al: Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Intensive Care Med 1998; 24:1199-1208
24. Yang Y, Loscalzo J: Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000; 101:2144-2148
25. Radomski MW, Moncada S: Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70:36-41
26. Radomski MW, Vallance P, Whitley G, et al: Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993; 27:1380-1382
27. Yao SK, Ober JC, Krishnaswami A, et al: Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992; 86:1302-1309
28. delaTorre A, Schroeder RA, Punzalan C, et al: Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 1999; 162:4101-4108
29. Peng HB, Libby P, Liao JK: Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270:14214-14219
30. De Caterina R, Libby P, Peng HB, et al: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-68
31. Spiecker M, Liao JK: Assessing induction of I kappa B by nitric oxide. Methods Enzymol 1999; 300:374-388
32. Spain DA, Wilson MA, Bar-Natan MF, et al: Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 1994; 36:720-725
33. Park JH, Chang SH, Lee KM, et al: Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 1996; 171:340-345
34. Spain DA, Wilson MA, Bar-Natan MF, et al: Role of nitric oxide in the small intestinal microcirculation during bacteremia. Shock 1994; 2:41-46
35. Spain DA, Wilson MA, Garrison RN: Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994; 116:322-330
36. Spronk PE, Ince C, Gardien MJ, et al: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396
37. Kalil AC, Sevransky JE, Myers DE, et al: Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit Care Med 2006; 34:2719-2728
38. Heyland DK, MacDonald S, Keefe L, et al: Total parenteral nutrition in the critically ill patient: A meta-analysis. JAMA 1998; 280:2013-2019
39. Marik PE, Zaloga GP: A meta-analysis of parenteral nutrition vs enteral nutrition in acute pancreatitis. BMJ 2004; 328:1407-1409
40. Marik PE, Pinsky MR: Death by total parenteral nutrition. Intensive Care Med 2003; 29:867-869
41. Freund H, Atamian S, Holroyde J, et al: Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979; 190:571-576
42. Argaman Z, Young VR, Noviski N, et al: Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med 2003; 31:591-597
43. Inoue Y, Bode BP, Souba WW, et al: Hepatic Na(+)-independent amino acid transport in endotoxemic rats: Evidence for selective stimulation of arginine transport. Shock 1994; 2:164-172
44. Sodeyama M, Gardiner KR, Regan MC, et al: Sepsis impairs gut amino acid absorption. Am J Surg 1993; 165:150-154
45. Gardiner KR, Ahrendt GM, Gardiner RE, et al: Failure of intestinal amino acid absorptive mechanisms in sepsis. J Am Coll Surg 1995; 181:431-436
46. Gardiner KR, Gardiner RE, Barbul A, et al: Reduced intestinal absorption of arginine during sepsis. Crit Care Med 1995; 23:1227-1232
47. Nijveldt RJ, Teerlink T, van Leeuwen PA, et al: The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003; 22:99-104
48. Nijveldt RJ, Teerlink T, Van Der HB, et al: Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22:23-30
49. Luiking YC, Poeze M, Dejong CH, et al: Sepsis: An arginine deficiency state? Crit Care Med 2004; 32:2135-2145
50. Galban C, Montejo JC, Mesejo A, et al: An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643-648
51. Grover R, Lopez A, Lorente J, et al: Multicenter, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Abstr. Crit Care Med 1999; 27(Suppl):A33
52. Klasen S, Hammermann R, Fuhrmann M, et al: Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001; 132:1349-1357
53. Bernard AC, Mistry SK, Morris SM Jr, et al: Alterations in arginine metabolic enzymes in trauma. Shock 2001; 15:215-219
54. Ochoa JB, Bernard AC, O'Brien WE, et al: Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233:393-399
55. Tsuei BJ, Bernard AC, Shane MD, et al: Surgery induces human mononuclear cell arginase I expression. J Trauma 2001; 51:497-502
56. Ochoa JB, Bernard AC, Mistry SK, et al: Trauma increases extrahepatic arginase activity. Surgery 2000; 127:419-426